BE849615A - Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b - Google Patents

Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b

Info

Publication number
BE849615A
BE849615A BE173436A BE173436A BE849615A BE 849615 A BE849615 A BE 849615A BE 173436 A BE173436 A BE 173436A BE 173436 A BE173436 A BE 173436A BE 849615 A BE849615 A BE 849615A
Authority
BE
Belgium
Prior art keywords
chronic hepatitis
virus infections
treat acute
new medicine
medicine
Prior art date
Application number
BE173436A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE849615A publication Critical patent/BE849615A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE173436A 1975-12-23 1976-12-20 Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b BE849615A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7539493A FR2336141A1 (fr) 1975-12-23 1975-12-23 Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b

Publications (1)

Publication Number Publication Date
BE849615A true BE849615A (fr) 1977-06-20

Family

ID=9164075

Family Applications (1)

Application Number Title Priority Date Filing Date
BE173436A BE849615A (fr) 1975-12-23 1976-12-20 Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b

Country Status (9)

Country Link
US (1) US4087519A (de)
JP (1) JPS6053009B2 (de)
AT (1) AT360643B (de)
BE (1) BE849615A (de)
CA (1) CA1090701A (de)
DE (1) DE2658170C2 (de)
FR (1) FR2336141A1 (de)
GB (1) GB1569000A (de)
NL (1) NL7614367A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4346073A (en) * 1980-04-11 1982-08-24 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
US5274081A (en) * 1989-09-20 1993-12-28 Immuno A.G. Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
US5576175A (en) * 1989-09-20 1996-11-19 Immuno Aktiengesellschaft Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
EP0447984A1 (de) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2155218A1 (de) * 1970-11-09 1972-09-21 Tokyo Standard Serums, Ltd , Tokio Anti Austrahenantigen Antiserum und Vei fahren zu seiner Herstellung
JPS4948730A (de) * 1972-09-08 1974-05-11

Also Published As

Publication number Publication date
CA1090701A (fr) 1980-12-02
US4087519A (en) 1978-05-02
JPS5290620A (en) 1977-07-30
FR2336141B1 (de) 1978-11-03
GB1569000A (en) 1980-06-11
AT360643B (de) 1981-01-26
ATA958876A (de) 1980-06-15
DE2658170A1 (de) 1977-07-07
NL7614367A (nl) 1977-06-27
FR2336141A1 (fr) 1977-07-22
JPS6053009B2 (ja) 1985-11-22
DE2658170C2 (de) 1985-05-15

Similar Documents

Publication Publication Date Title
BE754935A (fr) 2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation
BE788761A (fr) Ensemble de canule d'infusion
BE849615A (fr) Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b
BE788752A (fr) Copolymeres de 1-alcenes et de derives d'acides acryliques, et procede pour leur preparation
BE770966A (fr) Induction de l'interferon par les amines, chez les animaux
BE854640A (fr) Preparation de cefalexine a action prolongee pour le traitement efficace des infections par bacteries sensibles a la cefalexine
BE803771A (fr) Derives de l'acide 4-hydroxy-3,5-di-alcoyl-phenyl-propionique, leur preparation et leur application
BE781996A (fr) Preparation continue de l'ethylene-bis-diacetamide
BE773121A (fr) Preparations pharmaceutiques destinees au traitement des hyperlipidemies et leur procede d'obtention
BE790287A (fr) Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
BE803830A (fr) Preparation pour traiter les gastrites et ulceres
AT310931B (de) Einmal-Katheter
BE841083A (fr) Procede d'inhibition de l'agregation des plaquettes sanguines
BE788222A (fr) Textiles traites par de l'uree-formaldehyde
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis
FR2310770A1 (fr) Medicament pour le traitement de l'alopecia areata
FR2310767A1 (fr) Medicament pour le traitement de l'alopecia chronica diffusa
BE791772A (fr) Derives d'acides phenoxy-acetiques, leur preparation et leur application en therapeutique
BE787809A (fr) Derives de l'acide phenylacetique, leur procede de preparation et composition therapeutique les contenant
BE791253A (fr) Nouvelles preparations pharmaceutiques pour le traitement de l'hypertonie
BE779145A (fr) Nouveaux derives de l'amino-2 hydroxy-3 pyridine
BE780472A (fr) Derives de l'acide penicilloique
BE839736A (fr) Canule pour petites veines

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: INSTITUT MERIEUX

Effective date: 19881231